Strengthening Active Drug Safety Monitoring and Management (aDSM) in DR-TB care: Building resilient and sustainable safety monitoring systems
KNCV is hosting an opportunity to explore practical experiences, lessons learned, and innovative approaches to advancing DR-TB prevention, diagnosis and access.
28 of October, 2026
This webinar is part of the Unitaid-funded project ASCENT DR-TB led by KNCV Tuberculosis Foundation.
The introduction of new and improved treatment regimens for drug-resistant tuberculosis (DR-TB), including BPaL and BPaLM, brings important opportunities for people affected by DR-TB. Ensuring the safety of these treatments, however, requires strong systems to identify, manage and report adverse events throughout care.
Under the Unitaid-funded ASCENT DR-TB project, active Drug Safety Monitoring and Management (aDSM) has been a key intervention supporting the safe implementation of new DR-TB treatment regimens. ASCENT has worked to strengthen healthcare worker capacity through training and mentorship, improve adverse event detection, management and reporting, strengthen pharmacovigilance systems, and foster collaboration between TB programs and regulatory authorities.
Effective safety monitoring goes beyond health systems. ASCENT DR-TB has also promoted community engagement in treatment safety monitoring, supporting people with TB and communities to play an active role in identifying and reporting adverse events.
This webinar offered participants an opportunity to learn from practical experiences across different settings and explore how policy support, capacity strengthening, community engagement, multisectoral collaboration and market-shaping approaches can contribute to better TB prevention, diagnosis and care.
Webinar: Strengthening Active Drug Safety Monitoring and Management (aDSM) in DR-TB care: Building resilient and sustainable safety monitoring systems
Date:
28 of October, 2026
What will be covered?
- The role of aDSM in the implementation of new DR-TB drugs and regimens.
- Understanding adverse event detection, grading, management, recording and reporting.
- Ways to improve coordination between TB and pharmacovigilance systems.
- Practical experiences and lessons from ASCENT DR-TB implementation in Indonesia and Vietnam.
- Indonesia's experience in strengthening frontline capacity for aDSM through mentorship and clinical monitoring.
- Vietnam's experience scaling up aDSM to support nationwide implementation of BPaL/M regimens.
- Approaches to community-led pharmacovigilance and the role of treatment literacy and community engagement in improving safety monitoring.
Experts
Moderators:
- Chikosa Nguira - Unitaid
- Gidado Mustapha - KNCV Tuberculosis Foundation
Speakers:
- Dr.Thuy - PMDT Lead (National TB Program Vietnam)
- Ngoc Anh - (SCDI Vietnam)
- Mike Frick - TB Project Co-Director (Treatment Action Group - TAG)
